Are there altered antibody responses to measles, mumps, or rubella viruses in autism?

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington, DC 2000
   Google Scholar
• Asher D M. Slow viral infections of the human nervous system. Infections of the central nervous system, W M Scheld, R J Whitley, D T Durack. Raven Press, New York 1991; 145–166
   Google Scholar
• Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63–77
   PubMed Web of Science ®Google Scholar
• Bernard C C, Townsend E, Randell V B, Williamson H G. Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?. Clin Exp Immunol 1983; 52: 98–106
   Google Scholar
• Borenstein M, Rothstein H, Cohen J. Power and Precision, version 2.0. 2000, http://www.PowerAndPrecision.com
   Google Scholar
• Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001; 285: 3093–3099
   PubMed Web of Science ®Google Scholar
• Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971; 1: 33–47
   PubMedGoogle Scholar
• Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr 1977; 7: 69–81
   PubMedGoogle Scholar
• Coleman M, Gillberg C. The biology of the autistic syndromes. Praeger Publishers, New York 1985
   Google Scholar
• Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 2002; 32: 1457–1463
   PubMed Web of Science ®Google Scholar
• Dales L, Hammer S J, Smith N J. Time trends in autism and in MMR immunization coverage in California. JAMA 2001; 285: 1183–1185
   PubMed Web of Science ®Google Scholar
• Ferrari P, Marescot M R, Moulias R, Bursztejn C, Deville Chabrolle A, Thiollet M, Lesourd B, Braconnier A, Dreux C, Zarifian E, Fermanian J. Immune status in infantile autism. Correlation between the immune status, autistic symptoms and levels of serotonin. Encephale 1988; 14: 339–344
   Google Scholar
• Fombonne E. The prevalence of autism. JAMA 2003; 289: 87–89
   PubMed Web of Science ®Google Scholar
• Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001; 108: E58
   PubMed Web of Science ®Google Scholar
• Fujinami R S, Oldstone M BA. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol 1980; 125: 78–85
   Google Scholar
• Garg R K. Subacute sclerosing panencephalitis. Postgrad Med J 2002; 78: 63–70
   PubMed Web of Science ®Google Scholar
• Gillberg C, Wing L. Autism: not an extremely rare disorder. Acta Psychiatr Scand 1999; 99: 399–406
   PubMed Web of Science ®Google Scholar
• Goldberg W A, Osann K, Filipek P A, Laulhere T, Jarvis K, Modahl C, Flodman P, Spence M A. Language and other regression: assessment and timing. J Autism Dev Disord 2003; 33: 607–616
   PubMed Web of Science ®Google Scholar
• Gupta S, Aggarwal S, Heads C. Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 1996; 26: 439–452
   PubMed Web of Science ®Google Scholar
• Jahnke U, Fischer E H, Alvord E C, Jr. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 1985; 229: 282–284
   PubMed Web of Science ®Google Scholar
• Jankovic J. Tourette's syndrome. N Engl J Med 2001; 345: 1184–1192
   PubMed Web of Science ®Google Scholar
• Jansen V AA, Stollenwerk N, Jensen H J, Ramsay M E, Edmunds W J, Rhodes C J. Measles outbreaks in a population with declining vaccine uptake. Science 2003; 301: 804
   PubMed Web of Science ®Google Scholar
• Jingwu Z, Chin Y, Henderikx P, Medaer R, Chou C-HJ, Raus J C. Antibodies to myelin basic protein and measles virus in multiple sclerosis: precursor frequency analysis of the antibody producing B cells. Autoimmunity 1991; 11: 27–34
   Web of Science ®Google Scholar
• Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 2000; 45: 723–729
   PubMed Web of Science ®Google Scholar
• Kaye J A, Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001; 322: 460–463
   PubMed Web of Science ®Google Scholar
• Kennedy R C, Byers V S, Marchalonis J J. Measles virus infection and vaccination: potential role in chronic illness and associated adverse events. Crit Rev Immunol 2004; 24: 129–156
   PubMed Web of Science ®Google Scholar
• Kiessling L S, Marcotte A C, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993; 92: 39–43
   PubMed Web of Science ®Google Scholar
• King J C, Jr, Lichenstein R, Feigelman S, Luna C, Permutt T J, Patel J. Measles, mumps, and rubella antibodies in vaccinated Baltimore children. Am J Dis Child 1993; 147: 558–560
   Google Scholar
• Kirkman N J, Libbey J E, Sweeten T L, Coon H H, Miller J N, Stevenson E K, Lainhart J E, McMahon W M, Fujinami R S. How relevant are GFAP autoantibodies in autism?. J Autism Dev Disord 2007, in press
   Google Scholar
• Libbey J E, Sweeten T L, McMahon W M, Fujinami R S. Autistic disorder and viral infections. J NeuroVirol 2005; 11: 1–10
   PubMed Web of Science ®Google Scholar
• Libbey J E, Coon H H, Kirkman N J, Sweeten T L, Miller J N, Stevenson E K, Lainhart J E, McMahon W M, Fujinami R S. Are there enhanced MBP autoantibodies in autism?. J Autism Dev Disord 2007, in press
   Google Scholar
• Lord C, Risi S, Lambrecht L, Cook E H, Jr, Leventhal B L, DiLavore P C, Pickles A, Rutter M. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205–223
   PubMed Web of Science ®Google Scholar
• Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659–685
   PubMed Web of Science ®Google Scholar
• Luyster R, Richler J, Risi S, Hsu W-L, Dawson G, Bernier R, Dunn M, Hepburn S, Hyman S L, McMahon W M, Goudie-Nice J, Minshew N, Rogers S, Sigman M, Spence M A, Goldberg W A, Tager-Flusberg H, Volkmar F R, Lord C. Early regression in social communication in autism spectrum disorders: a CPEA Study. Dev Neuropsychol 2005; 27: 311–336
   PubMed Web of Science ®Google Scholar
• Madsen K M, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002; 347: 1477–1482
   PubMed Web of Science ®Google Scholar
• Madsen K M, Vestergaard M. MMR vaccination and autism: what is the evidence for a causal association?. Drug Saf 2004; 27: 831–840
   Google Scholar
• Mäkelä A, Nuorti J P, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 2002; 110: 957–963
   PubMed Web of Science ®Google Scholar
• Nelson K B. Prenatal and perinatal factors in the etiology of autism. Pediatrics 1991; 87: 761–766
   PubMedGoogle Scholar
• Panitch H S, Hooper C J, Johnson K P. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol 1980; 37: 206–209
   PubMedGoogle Scholar
• Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351: 1327–1328
   PubMed Web of Science ®Google Scholar
• Peterson M R, Torrey E F. Viruses and other infectious agents as behavioral teratogens. The autistic syndromes, M Coleman. American Elsevier, New York 1976; 23–42
   Google Scholar
• Plioplys A V. Intravenous immunoglobulin treatment of children with autism. J Child Neurol 1998; 13: 79–82
   PubMed Web of Science ®Google Scholar
• Plioplys A V, Greaves A, Kazemi K, Silverman E. Immunoglobin reactivity in autism and Rett's syndrome. Dev Brain Dysfunct 1994; 7: 12–16
   Google Scholar
• Rice G PA, Fujinami R S. Measles virus. Methods of enzymatic analysis, H U Bergmeyer. VCH Publishers: Deerfield Beach, Deerfield Beach, FL 1986; 370–383
   Google Scholar
• Richler J, Luyster R, Risi S, Hsu W-L, Dawson G, Bernier R, Dunn M, Hepburn S, Hyman S L, McMahon W M, Goudie-Nice J, Minshew N, Rogers S, Sigman M, Spence M A, Goldberg W A, Tager-Flusberg H, Volkmar F R, Lord C. Is there a ‘regressive phenotype’ of autism spectrum disorder associated with the measles-mumps-rubella vaccine? A CPEA study. J Autism Dev Disord 2006; 36: 299–316
   PubMedGoogle Scholar
• Rubio N, Cuesta A. Lack of cross-reaction between myelin basic proteins and putative demyelinating virus envelope proteins. Mol Immunol 1989; 26: 663–668
   Google Scholar
• Schotte A, Janssen P F, Megens A A, Leysen J E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 1993; 631: 191–202
   Google Scholar
• Singh V K, Jensen R L. Elevated levels of measles antibodies in children with autism. Pediatr Neurol 2003; 28: 292–294
   PubMed Web of Science ®Google Scholar
• Singh V K, Lin S X, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 2002; 9: 359–364
   PubMed Web of Science ®Google Scholar
• Singh V K, Lin S X, Yang V C. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 1998; 89: 105–108
   PubMedGoogle Scholar
• Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues L C, Smith P G, Hall A J. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004; 364: 963–969
   PubMed Web of Science ®Google Scholar
• Stubbs E G. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr 1976; 6: 269–274
   PubMedGoogle Scholar
• Swedo S E, Leonard H L, Garvey M, Mittleman B, Allen A J, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert B K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264–271
   PubMed Web of Science ®Google Scholar
• Sweeten T L, Fujinami R S. A potential link between measles virus and autism: age-matched control groups are essential. Pediatr Neurol 2004; 30: 78
   Google Scholar
• Taylor B, Miller E, Farrington C P, Petropoulos M C, Favot-Mayaud I, Li J, Waight P A. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026–2029
   PubMed Web of Science ®Google Scholar
• Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002; 324: 393–396
   PubMed Web of Science ®Google Scholar
• Thomas D RH, Salmon R L, King J. Rates of first measles-mumps-rubella immunisation in Wales (UK). Lancet 1998; 351: 1927
   Google Scholar
• Tookey P. Rubella in England, Scotland and Wales. Euro Surveill 2004; 9: 21–23
   Google Scholar
• Trajkovski V, Ajdinski L, Spiroski M. Plasma concentration of immunoglobulin classes and subclasses in children with autism in the Republic of Macedonia: retrospective study. Croat Med J 2004; 45: 746–749
   PubMedGoogle Scholar
• Uhlmann V, Martin C M, Sheils O, Pilkington L, Silva I, Killalea A, Murch S B, Wakefield A J, O'Leary J J. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002; 55: 84–90
   PubMedGoogle Scholar
• Wakefield A J, Ashwood P, Limb K, Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 2005; 17: 827–836
   PubMed Web of Science ®Google Scholar
• Wakefield A J, Murch S H, Anthony A, Linnell J, Casson D M, Malik M, Berelowitz M, Dhillon A P, Thomson M A, Harvey P, Valentine A, Davies S E, Walker-Smith J A. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637–641
   PubMed Web of Science ®Google Scholar
• Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003; 289: 49–55
   PubMed Web of Science ®Google Scholar
• Yeh C-B, Wu C-H, Tsung H-C, Chen C-W, Shyu J-F, Leckman J F. Antineural antibody in patients with Tourette's syndrome and their family members. J Biomed Sci 2006; 13: 101–112
   Google Scholar
• Zimmerman A W, Potter N T, Stakkestad A, Frye V H. Serum immunoglobulins and autoimmune profiles in children with autism. Ann Neurol 1995; 38: 528
   Google Scholar